Please provide your email address to receive an email when new articles are posted on . Trifluridine-tipiracil plus bevacizumab was not superior to capecitabine plus bevacizumab but presented no new ...

Toremifene Improves Lipid Profiles in Men Receiving Androgen-Deprivation Therapy for Prostate Cancer: Interim Analysis of a Multicenter Phase III Study Fifty-six patients with metastatic CRC with ...

Positive data announced from Phase 1 Dose Expansion Study of varsetatug masetecan (“Varseta-M”) EpCAM PROBODY® ADC in Patients with Advanced Colorectal Cancer (CRC) - - Enrollment of 40 patients in ...

Canadian experience managing dose intensity of regorafenib in relation to safety and clinical outcome in metastatic colorectal cancer patients. This is an ASCO Meeting Abstract from the 2016 ASCO ...

Compared with originator bevacizumab, the biosimilar version of bevacizumab had equal efficacy when used to treat metastatic colorectal cancer. CRC is among the most common cancers worldwide while ...

The trial assesses Precem-TcT efficacy and safety alone or with bevacizumab in mCRC patients after previous therapies.

SAN FRANCISCO — Maintenance treatment with capecitabine (Xeloda) and bevacizumab (Avastin) significantly delayed disease progression, compared with observation, in patients with metastatic colorectal ...

RP3 will be developed in combination with atezolizumab and bevacizumab for the third-line treatment of colorectal cancer (CRC) and for the first- and second-line treatment of hepatocellular carcinoma ...

The recent FDA approval of Lonsurf plus Avastin for metastatic colorectal cancer improves survival and quality of life, an expert said. The Food and Drug Administration's (FDA) recent approval of ...

SUNLIGHT "is the first phase 3 study in the setting of refractory metastatic colorectal cancer to demonstrate an improvement in overall survival versus an active control," say the trial investigators.

TAS-102 plus bevacizumab is cost-effective in China but not in the US or UK due to high incremental cost-effectiveness ratios (ICERs). The study uses a decision model to compare TAS-102 monotherapy ...